110 likes | 114 Vues
Fig 4.1 95% confidence limits for prevalence of 725 pmp for population size 50,000 - 600,000. UK Renal Registry 10th Annual Report 2007. Fig 4.2 95% confidence limits for prevalence of 725 pmp for population size 50,000 – 4 million. UK Renal Registry 10th Annual Report 2007.
E N D
Fig 4.1 95% confidence limits for prevalence of 725 pmp for population size 50,000 - 600,000 UK Renal Registry 10th Annual Report 2007
Fig 4.2 95% confidence limits for prevalence of 725 pmp for population size 50,000 – 4 million UK Renal Registry 10th Annual Report 2007
Fig 4.3 Growth in prevalent patients, by treatment modality at the end of each year, 1982-2006 UK Renal Registry 10th Annual Report 2007
Fig 4.4 Percentage non-Whites in areas with significantly low, normal and significantly high SPR values (median and quartiles) on 31/12/2006 UK Renal Registry 10th Annual Report 2007
Fig 4.5 Ethnicity and standardised prevalence ratio for all covered local authorities on 31/12/2006 UK Renal Registry 10th Annual Report 2007
Fig 4.6 Age distribution (1 year age bands) of prevalent RRT patients split by treatment modality (dialysis or transplant) on 31/12/2006 UK Renal Registry 10th Annual Report 2007
Fig 4.7 Age profile of prevalent RRT patients by gender on 31/12/2006 UK Renal Registry 10th Annual Report 2007
Fig 4.8 Crude Rate per Million Population by Age and Gender for the UK stock on 31/12/2006 UK Renal Registry 10th Annual Report 2007
Fig 4.9 Treatment modality in prevalent RRT patients on 31/12/2006 UK Renal Registry 10th Annual Report 2007
Fig 4.10 Treatment modality distribution by age in prevalent RRT patients on 31/12/2006 UK Renal Registry 10th Annual Report 2007
Fig 4.11 Proportion of prevalent dialysis patients on HD by age group on 31/12/2006 UK Renal Registry 10th Annual Report 2007